Zhengye Biotechnology Holding Ltd

Research Zhengye Biotechnology Holding Ltd (ZYBT) on Bullrun: market cap USD 32.80M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerZYBT
• ExchangeNASDAQ
• CountryChina
• SectorHealthcare
• IndustryDrug Manufacturers-Specialty & Generic
• CurrencyUSD
• Market capUSD 32.80M
• Financial periodFY2025
• RevenueUSD 16.64M
• Revenue growth-91.1%
• Net income-USD 9.98M
• Free cash flowUSD 1.77M
• Gross margin20.5%

Valuation Snapshot

latest market cap is USD 32.80M.

About Zhengye Biotechnology Holding Ltd

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs.

Frequently asked questions

What is Zhengye Biotechnology Holding Ltd's market cap?

Zhengye Biotechnology Holding Ltd's market capitalization is USD 32.80M.

What does Zhengye Biotechnology Holding Ltd do?

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China.